ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANXIETY;
BACTERIAL CELL WALL;
BACTERICIDAL ACTIVITY;
CONVULSION;
DEPRESSION;
DROWSINESS;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG SAFETY;
DRUG SENSITIVITY;
DRUG SOLUBILITY;
DRUG TARGETING;
DRUG TOLERABILITY;
GENE MUTATION;
GENETIC MANIPULATION;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
LD 50;
MACROPHAGE;
MOUSE;
MYCOBACTERIUM AVIUM;
MYCOBACTERIUM SMEGMATIS;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PARALYSIS;
PRIORITY JOURNAL;
RAT;
REVIEW;
SEIZURE;
SIDE EFFECT;
SLURRED SPEECH;
TUBERCULOSIS;
UNCONSCIOUSNESS;
Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
Di Perri G., and Bonora S. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?. J Antimicrob Chemother 54 (2004) 593-602
Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis
Fattorini L., et al. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Microb Drug Resist 5 (1999) 265-270
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996 2000
Lu P., et al. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996 2000. Int J Antimicrob Agents 21 (2003) 239-243
Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy
Balabanova Y., et al. Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy. Eur J Clin Microbiol Infect Dis 24 (2005) 136-139
In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages
Rastogi N., et al. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol 33 (1996) 167-175
Activities of poloxamer CRL8131 against Mycobacterium tuberculosis in vitro and in vivo
Jagannath C., et al. Activities of poloxamer CRL8131 against Mycobacterium tuberculosis in vitro and in vivo. Antimicrob Agents Chemother 39 (1995) 1349-1354
Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice
Fattorini L., et al. Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice. Antimicrob Agents Chemother 47 (2003) 360-362